Effectiveness of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis carrying non-F508del variants in Brazil.

Canan MGM, Sokoloski CS, Dalcin PTR, de Oliveira RFJ, Ziegler B, Rached SZ, Silva DCCE, da Silva LVRF, Pinto LA, Athanazio RA

Open source

DOI: 10.36416/3086-3910/e20250384
Published: 2026
Container: Respiratory research & clinical practice
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.36416/3086-3910/e20250384,
  title = {Effectiveness of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis carrying non-F508del variants in Brazil.},
  author = {Canan MGM and Sokoloski CS and Dalcin PTR and de Oliveira RFJ and Ziegler B and Rached SZ and Silva DCCE and da Silva LVRF and Pinto LA and Athanazio RA},
  year = {2026},
  journal = {Respiratory research \& clinical practice},
  doi = {10.36416/3086-3910/e20250384},
  url = {https://doi.org/10.36416/3086-3910/e20250384}
}

RIS

TY  - JOUR
TI  - Effectiveness of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis carrying non-F508del variants in Brazil.
AU  - Canan MGM
AU  - Sokoloski CS
AU  - Dalcin PTR
AU  - de Oliveira RFJ
AU  - Ziegler B
AU  - Rached SZ
AU  - Silva DCCE
AU  - da Silva LVRF
AU  - Pinto LA
AU  - Athanazio RA
PY  - 2026
JO  - Respiratory research & clinical practice
DO  - 10.36416/3086-3910/e20250384
UR  - https://doi.org/10.36416/3086-3910/e20250384
ER  -

APA

MGM, C., CS, S., PTR, D., RFJ, D. O., B, Z., SZ, R., DCCE, S., LVRF, D. S., LA, P., & RA, A. (2026). Effectiveness of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis carrying non-F508del variants in Brazil.. Respiratory research & clinical practice. https://doi.org/10.36416/3086-3910/e20250384

Source records

pubmed · retrieved 2026-09-26T05:16:40.090Z